Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi
Pre-treatment drug resistance (PDR) among antiretroviral drug-naïve people living with HIV (PLHIV) represents an important indicator for the risk of treatment failure and the spread of drug resistant HIV variants. We assessed the prevalence of PDR and treatment outcomes among adults living with HIV...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 May 2020
|
| In: |
AIDS research and therapy
Year: 2020, Volume: 17, Issue: 1, Pages: 1-7 |
| ISSN: | 1742-6405 |
| DOI: | 10.1186/s12981-020-00282-3 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12981-020-00282-3 Verlag, lizenzpflichtig, Volltext: https://aidsrestherapy.biomedcentral.com/articles/10.1186/s12981-020-00282-3 |
| Author Notes: | F. Neuhann, A. de Forest, E. Heger, A. Nhlema, C. Scheller, R. Kaiser, H.M. Steffen, H. Tweya, G. Fätkenheuer and S. Phiri |
| Summary: | Pre-treatment drug resistance (PDR) among antiretroviral drug-naïve people living with HIV (PLHIV) represents an important indicator for the risk of treatment failure and the spread of drug resistant HIV variants. We assessed the prevalence of PDR and treatment outcomes among adults living with HIV-1 in Lilongwe, Malawi. |
|---|---|
| Item Description: | Gesehen am 31.03.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1742-6405 |
| DOI: | 10.1186/s12981-020-00282-3 |